TGH Cancer Institute I Cancer Center of South Florida Welcomes World-Renowned Physician Scientist and Head & Neck Oncologist Dr. Marshall Posner

Posner adds a strong clinical and research focus to the practice, expanding the world-class, complex cancer care Tampa General Hospital offers patients in Palm Beach and Martin counties, as well as across Florida.

 

West Palm Beach, FL (Oct. 24, 2024) – TGH Cancer Institute | Cancer Center of South Florida (CCSF) welcomed world-renowned physician scientist and head and neck oncologist Dr. Marshall Posner to its practice, effective Oct. 1.

 

“Dr. Posner will be an invaluable asset to the practice,” said Dr. Abraham Schwarzberg, chief of oncology at TGH Cancer Institute | CCSF. “He brings a stellar reputation as an oncologist, plus a wealth of knowledge and experience as a clinical researcher that will help continue to expand the world-class, advanced care we provide patients.”

 

Posner joins TGH Cancer Institute | CCSF from the Icahn School of Medicine at Mount Sinai in New York City, where he was a professor of medicine and medical director of the head and neck oncology program. He is board-certified in internal medicine and medical oncology.

At TGH Cancer Institute | CCSF, Posner’s clinical practice will focus on head and neck cancers, thyroid cancer and cutaneous malignancies of the head and neck. He will serve as medical director of the Cancer Center Clinical Research Trial Office. Through Posner’s work, local cancer patients will have expanded access to groundbreaking cancer trials.

“In addition to providing head and neck cancer patients with personalized, impeccable and cutting-edge care, Dr. Posner will also serve as a bridge for patients in Palm Beach and Martin counties looking to gain access to and participate in game-changing and innovative cancer clinical trials,” Schwarzberg said.

In addition to his responsibilities in the Palm Beaches, Posner will lend his expertise to consult on complex patients at Tampa General Hospital’s main campus. Research trials conducted by this world-renowned leader in head and neck cancers will be available to patients across the Tampa General academic health care system.

Posner has performed seminal studies in induction chemotherapy and de-escalation treatment in HPV-related oropharyngeal cancer. He has published more than 285 peer-reviewed laboratory and clinical studies. He has been the principal investigator of National Institutes of Health (NIH) grants in immunology and of multiple Phase 1, 2, and 3 clinical trials. His research and clinical practice have most recently been aimed at immunotherapy, HPV oropharyngeal cancer and salivary gland cancers.

“As we continue to assemble an academic-based, national-caliber research team to lead the way in finding permanent solutions to fight cancer, Dr. Posner will play an important role on our journey to discover scientific breakthroughs in cancer care. If we think about the driving force in all the major advances and practice-changing clinical trials in head and neck malignancies, the name of Dr. Posner immediately came to mind,” said Dr. Eduardo Sotomayor, vice president and executive director of the TGH Cancer Institute. “In addition to his role as a lead clinical investigator in head and neck malignancies, Dr. Posner will help with the building of the microbial oncology program, as it relates to human-papillomavirus (HPV)-related cancers.”

TGH Cancer Institute | CCSF’s experts collaborate to provide comprehensive treatment options. One of Florida’s few cancer centers backed by academic medicine, the TGH Cancer Institute ranks among the nation’s top 50 cancer centers in U.S. News & World Report’s 2024-2025 Best Hospitals. The Institute provides comprehensive care via groundbreaking therapies, advanced diagnostic imaging tools and a highly coordinated, interdisciplinary approach to world-class patient care. It is certified by the American College of Surgeons Commission on Cancer Accreditation and is named one of America’s Best Cancer Hospitals by Newsweek. 

Posner graduated from Yale University in 1971 and Tufts University School of Medicine in 1975. He completed his residency in internal medicine at Boston City Hospital and a fellowship in medical oncology at the Dana-Farber Cancer Institute at Harvard Medical School, Boston in 1981. Before joining Mount Sinai, he was the medical director of head and neck oncology at the Dana-Farber Cancer Institute.

“TGH Cancer Institute | CCSF has assembled an innovative practice, composed of passionate and compassionate physicians, firmly dedicated to delivering patients with unmatched, comprehensive care,” Posner said. “I am both excited and humbled to join such a talented team, and I look forward to our collaboration.”

Since 2020, Tampa General Hospital has been creating a framework of state-of-the-art services for patients in Palm Beach and Martin counties with the expertise and innovation of a preeminent academic health system.

One of the leading academic health systems in the nation, Tampa General is the primary teaching affiliate of the USF Health Morsani College of Medicine. Tampa General Hospital has been affiliated with the USF Health Morsani College of Medicine since the school was created in the early 1970s. Today, more than 700 medical school residents and fellows receive specialty training at the academic health system in areas ranging from general internal medicine to neurosurgery.

 

For more information about TGH Cancer Institute | Cancer Center of South Florida, click here.